Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.
Iihara H, Shimokawa M, Bando H, Niwa Y, Mizuno Y, Kawaguchi Y, Kitahora M, Murakami A, Kawai M, Ishida K, Takeuchi M, Ishihara K, Iyoda T, Nakada T, Ogiso A, Kojima Y, Kumagai F, Sawa A, Mori R, Higuchi K, Furuta T, Kamei Y, Tsuchiya M, Terasaki A, Yamamoto S, Kitazawa M, Okazaki M, Suzuki A, Futamura M. Iihara H, et al. Among authors: shimokawa m. J Cancer. 2023 Aug 28;14(14):2644-2654. doi: 10.7150/jca.87169. eCollection 2023. J Cancer. 2023. PMID: 37779870 Free PMC article.
New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm.
Fukushima R, Harimoto N, Okuyama T, Seki T, Hoshino K, Hagiwara K, Kawai S, Ishii N, Tsukagoshi M, Igarashi T, Araki K, Tomonaga H, Higuchi T, Shimokawa M, Shirabe K. Fukushima R, et al. Among authors: shimokawa m. Int J Clin Oncol. 2024 May 20. doi: 10.1007/s10147-024-02553-9. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38769190
Impact on the image quality of modified reduced field-of-view diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinoma using spatially tailored two-dimensional radiofrequency pulses with a tilted excitation plane: A comparison with conventional field-of-view imaging.
Tanabe M, Hideura K, Higashi M, Ihara K, Inoue A, Narikiyo K, Benkert T, Imai H, Yamane M, Yamaguchi T, Shimokawa M, Ito K. Tanabe M, et al. Among authors: shimokawa m. Eur J Radiol. 2023 Nov;168:111138. doi: 10.1016/j.ejrad.2023.111138. Epub 2023 Oct 6. Eur J Radiol. 2023. PMID: 37832196
Assessing the ability of the Cancer and Aging Research Group tool to predict chemotherapy toxicity in older Japanese patients: A prospective observational study.
Uchiyama M, Miyazaki M, Hayashi T, Shimokawa M, Nakano T, Kakimoto H, Takaki S, Fukue H, Inoue T, Inoue R, Mashima K, Kawata S, Sumi Y, Igarashi Y, Kamimura H, Imakyure O, Matsuo K. Uchiyama M, et al. Among authors: shimokawa m. J Geriatr Oncol. 2024 Jun 7;15(6):101814. doi: 10.1016/j.jgo.2024.101814. Online ahead of print. J Geriatr Oncol. 2024. PMID: 38851083
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer.
Kodama T, Imajima T, Shimokawa M, Otsuka T, Kawahira M, Nakazawa J, Hori T, Shibuki T, Arima S, Ido A, Miwa K, Okabe Y, Koga F, Ueda Y, Kubotsu Y, Shimokawa H, Takeshita S, Nishikawa K, Komori A, Otsu S, Hosokawa A, Sakai T, Sakai K, Oda H, Kawahira M, Arita S, Honda T, Taguchi H, Tsuneyoshi K, Kawaguchi Y, Fujita T, Sakae T, Shirakawa T, Mizuta T, Mitsugi K. Kodama T, et al. Among authors: shimokawa m. Sci Rep. 2024 May 30;14(1):12422. doi: 10.1038/s41598-024-63172-y. Sci Rep. 2024. PMID: 38816500 Free PMC article.
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
Nosaki K, Yoh K, Toyozawa R, Horinouchi H, Morise M, Ohashi K, Murakami H, Satouchi M, Sakakibara-Konishi J, Yano S, Okumura F, Matsumoto S, Shimokawa M, Seto T, Goto K. Nosaki K, et al. Among authors: shimokawa m. Int J Clin Oncol. 2024 May 17. doi: 10.1007/s10147-024-02543-x. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38758397
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.
Nakashoji A, Haratake N, Bhattacharya A, Mao W, Xu K, Wang K, Daimon T, Ozawa H, Shigeta K, Fushimi A, Yamashita N, Morimoto Y, Shimokawa M, Saito S, Egloff AM, Uppaluri R, Long MD, Kufe D. Nakashoji A, et al. Among authors: shimokawa m. Cancer Res Commun. 2024 May 14;4(5):1268-1281. doi: 10.1158/2767-9764.CRC-24-0011. Cancer Res Commun. 2024. PMID: 38619287 Free PMC article.
437 results